Fig. 6
From: The pseudoenzyme ADPRHL1 affects cardiac function by regulating the ROCK pathway
Blebbistatin improves electrical conduction and calcium transients of KO-CMs. A MEA detection of the electrical conduction velocity of WT-CMs, KO-CMs, WT-CMs treated with Blebbistatin and KO-CMs treated with Blebbistatin at day 20. B Representative line-scan images in WT-CMs, KO-CMs, WT-CMs treated with Blebbistatin and KO-CMs treated with Blebbistatin at day 20. C, D and E Quantification of peak, time to peak and calcium transient duration in WT-CMs, KO-CMs, WT-CMs treated with Blebbistatin and KO-CMs treated with Blebbistatin